Published in Clin Rheum Dis on April 01, 1983
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell (1992) 16.53
Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol (2000) 15.79
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature (1983) 3.56
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res (2001) 3.48
Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med (1990) 3.38
Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain (1991) 3.07
Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest (1976) 2.38
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood (1999) 2.22
Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination. Lancet (1995) 2.06
Diagnostic value of cervical discography in the management of cervical discogenic pain. Conn Med (2000) 1.99
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer (2013) 1.85
Oestrogen receptors and prognosis in early breast cancer. Lancet (1979) 1.83
Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation. J Clin Invest (1986) 1.43
Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis. Antimicrob Agents Chemother (1991) 1.39
Removal of the entrapped basketed ureteral calculus: a novel technique. J Urol (2000) 1.39
Methotrexate may lower seizure threshold in patients with epilepsy. J Rheumatol (1992) 1.39
Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol (1996) 1.35
Steroid receptors in early breast cancer: value in prognosis. J Steroid Biochem (1981) 1.31
Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc Natl Acad Sci U S A (1994) 1.29
The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. J Infect Dis (1991) 1.29
Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest (1980) 1.29
Hereditary C2 deficiency: diagnosis and HLA gene complex associations. J Immunol (1976) 1.28
Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem (1990) 1.28
Inherited deficiency of the sixth component of complement: a silent or null gene. J Immunol (1978) 1.27
Genetic characterization of wild and captive rhesus macaques in China. J Med Primatol (2008) 1.26
Squamous carcinoma of the breast. J Clin Pathol (1978) 1.23
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am J Hum Genet (1979) 1.22
Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol (1999) 1.22
Comparison of effects of long-term corticotrophin and corticosteroid treatment on responses of plasma growth hormone, ACTH, and corticosteroid to hypoglycaemia. Br Med J (1974) 1.21
Gold-induced thrombocytopenia. A clinical and immunogenetic study of twenty-three patients. Ann Intern Med (1981) 1.13
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer. J Clin Oncol (2001) 1.13
Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). Clin Cancer Res (1998) 1.12
Development of a Chinese-Indian hybrid (Chindian) rhesus macaque colony at the California National Primate Research Center by introgression. J Med Primatol (2008) 1.12
A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant (2004) 1.12
Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med (1978) 1.11
Microarray analysis detects novel Pax3 downstream target genes. J Biol Chem (2001) 1.11
Smoking-related diseases: the importance of COPD. Int J Tuberc Lung Dis (2004) 1.10
Syphilis partner notification with men who have sex with men: a review and commentary. Sex Transm Dis (2005) 1.07
Treatment options in renal cell carcinoma: past, present and future. Ann Oncol (2007) 1.07
Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis. Clin Infect Dis (1992) 1.06
Second-gradient models accounting for some effects of microstructure on remodelling of bones reconstructed with bioresorbable materials. Comput Methods Biomech Biomed Engin (2013) 1.05
Saperconazole therapy in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother (1992) 1.03
Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. Gene Ther (2004) 1.02
Corticosteroid and growth-hormone response to hypoglycaemia in patients on long-term treatment with corticotrophin. Lancet (1971) 1.01
Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol (1987) 1.01
Functional analysis of mutant neurotrophins deficient in low-affinity binding reveals a role for p75LNGFR in NT-4 signalling. EMBO J (1995) 1.00
The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement. J Clin Invest (1976) 1.00
Evolution of karyotypic abnormalities and C-MYC oncogene amplification in human colonic carcinoma cell lines. Chromosoma (1985) 0.99
Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol (2000) 0.99
Linkage analysis of X-linked mental retardation with and without fragile-X using factor IX gene probe. Lancet (1984) 0.98
Maternal/congenital syphilis in a large tertiary-care urban hospital. Clin Infect Dis (1993) 0.98
Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer. Gene Ther (2004) 0.98
Extended haplotypes of chromosome 6 in adult rheumatoid arthritis. Arthritis Rheum (1984) 0.97
The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res (2000) 0.96
Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration. J Med Virol (1997) 0.96
Rheumatoid vasculitis. Arthritis Rheum (1976) 0.94
Prevalence and correlates of depressive syndromes among adults visiting an Indian Health Service primary care clinic. Am Indian Alsk Native Ment Health Res (1995) 0.93
Oxygen and 99mTc-MAA shunt estimations in patients with pulmonary arteriovenous malformations: effects of changes in posture and lung volume. Thorax (1994) 0.93
Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease. J Neurol Sci (2002) 0.92
Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease. Am J Cardiol (1993) 0.92
Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance. Clin Infect Dis (2001) 0.92
Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors. Gene Ther (2010) 0.92
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Am J Med (1989) 0.91
Two integrated partial repeats of simian virus 40 together code for a super-T antigen. Mol Cell Biol (1985) 0.91
Complement-human histocompatibility antigen haplotypes in C2 deficiency. J Clin Invest (1981) 0.89
Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance. Proc Natl Acad Sci U S A (1993) 0.89
The location of C2, C4, and BF relative to HLA-B and HLA-D. Immunogenetics (1981) 0.89
A rapid quantitative real-time PCR-based DNA quantification assay coupled with species--assignment capabilities for two hybridizing Macaca species. Folia Primatol (Basel) (2011) 0.89
Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Exp Cell Res (2000) 0.89
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents. Bone Marrow Transplant (2010) 0.88
Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431. Cancer Res (1999) 0.88
Diagnostic value of the history and examination in giant cell arteritis: a clinical pathological study of 81 temporal artery biopsies. J Rheumatol (1988) 0.88
Non-HLA gene polymorphisms in juvenile rheumatoid arthritis. Clin Exp Rheumatol (2003) 0.88
Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. Genomics (1994) 0.87
Development of the neuromuscular junction: genetic analysis in mice. J Physiol Paris (1999) 0.87
Association between HLA and cutaneous necrotizing venulitis. Arthritis Rheum (1976) 0.87
Osteomalacia following vagotomy and pyloroplasty. Postgrad Med J (1971) 0.86
Overexpression of murine Pax3 increases NCAM polysialylation in a human medulloblastoma cell line. J Biol Chem (2000) 0.86
Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant (2007) 0.86
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. Transplantation (2000) 0.85
Cloning and applications of the two/three-base restriction endonuclease R.CviJI from IL-3A virus-infected Chlorella. Gene (1995) 0.85
Pericardial effusion post-SCT in pediatric recipients with signs and/or symptoms of cardiac disease. Bone Marrow Transplant (2010) 0.85
The early management of bilateral cleft of lip and palate. Br J Plast Surg (1970) 0.85
Molecular cloning of the three base restriction endonuclease R.CviJI from eukaryotic Chlorella virus IL-3A. Nucleic Acids Res (1996) 0.85
Single daily dose corticosteroid treatment. Ann Rheum Dis (1976) 0.85
Detection of S-nitrosothiols and other nitric oxide derivatives by photolysis-chemiluminescence spectrometry. Anal Biochem (1997) 0.84
Corn syrup sugars: in vitro and in vivo digestibility and clinical tolerance in acute diarrhea of infancy. J Pediatr (1983) 0.84
Feather lead concentrations and (207)Pb/(206)Pb ratios reveal lead exposure history of California Condors (Gymnogyps californianus). Environ Sci Technol (2010) 0.84
Effect of lifestyle changes on whole-body protein turnover in obese adolescents. Int J Obes Relat Metab Disord (2003) 0.83
Allergy to tetracosactrin-depot. Lancet (1971) 0.83
The syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes presenting without stroke. Arch Neurol (1993) 0.83
Building sickness, are symptoms related to the office lighting? Ann Occup Hyg (1989) 0.83
Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res (1999) 0.83
Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother Pharmacol (2001) 0.83
Agrin receptors at the skeletal neuromuscular junction. Ann N Y Acad Sci (1998) 0.82
Is farm-related job title an adequate surrogate for pesticide exposure in occupational cancer epidemiology? Occup Environ Med (2009) 0.82
Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant (2004) 0.82